vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $143.3M, roughly 1.4× Piedmont Realty Trust, Inc.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -31.4%, a 39.7% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 0.4%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 0.0%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
COLL vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $143.3M |
| Net Profit | $17.0M | $-45.0M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | -31.4% |
| Revenue YoY | 12.9% | 0.4% |
| Net Profit YoY | 35.3% | -27.9% |
| EPS (diluted) | $0.48 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $205.4M | $142.9M | ||
| Q3 25 | $209.4M | $139.2M | ||
| Q2 25 | $188.0M | $140.3M | ||
| Q1 25 | $177.8M | $142.7M | ||
| Q4 24 | $181.9M | $143.2M | ||
| Q3 24 | $159.3M | $139.3M | ||
| Q2 24 | $145.3M | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | $17.0M | $-43.2M | ||
| Q3 25 | $31.5M | $-13.5M | ||
| Q2 25 | $12.0M | $-16.8M | ||
| Q1 25 | $2.4M | $-10.1M | ||
| Q4 24 | $12.5M | $-30.0M | ||
| Q3 24 | $9.3M | $-11.5M | ||
| Q2 24 | $19.6M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | — | ||
| Q3 25 | 29.7% | — | ||
| Q2 25 | 18.7% | — | ||
| Q1 25 | 12.2% | — | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 32.7% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | 8.3% | -30.3% | ||
| Q3 25 | 15.0% | -9.7% | ||
| Q2 25 | 6.4% | -12.0% | ||
| Q1 25 | 1.4% | -7.1% | ||
| Q4 24 | 6.9% | -20.9% | ||
| Q3 24 | 5.9% | -8.3% | ||
| Q2 24 | 13.5% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $0.48 | $-0.34 | ||
| Q3 25 | $0.84 | $-0.11 | ||
| Q2 25 | $0.34 | $-0.14 | ||
| Q1 25 | $0.07 | $-0.08 | ||
| Q4 24 | $0.36 | $-0.25 | ||
| Q3 24 | $0.27 | $-0.09 | ||
| Q2 24 | $0.52 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $2.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.5B |
| Total Assets | $1.7B | $4.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $386.7M | $731.0K | ||
| Q3 25 | $285.9M | $3.0M | ||
| Q2 25 | $222.2M | $3.3M | ||
| Q1 25 | $197.8M | $2.9M | ||
| Q4 24 | $162.8M | $109.6M | ||
| Q3 24 | $120.0M | $133.6M | ||
| Q2 24 | $271.6M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $301.7M | $1.5B | ||
| Q3 25 | $274.8M | $1.5B | ||
| Q2 25 | $232.2M | $1.5B | ||
| Q1 25 | $234.4M | $1.6B | ||
| Q4 24 | $228.8M | $1.6B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $1.7B | $4.0B | ||
| Q3 25 | $1.6B | $4.0B | ||
| Q2 25 | $1.6B | $4.0B | ||
| Q1 25 | $1.6B | $4.0B | ||
| Q4 24 | $1.7B | $4.1B | ||
| Q3 24 | $1.6B | $4.1B | ||
| Q2 24 | $1.1B | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 1.41× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | — | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 110.3% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $140.6M | ||
| Q3 25 | $78.4M | $35.8M | ||
| Q2 25 | $72.4M | $50.1M | ||
| Q1 25 | $55.4M | $3.7M | ||
| Q4 24 | $84.6M | $198.1M | ||
| Q3 24 | $-9.0M | $42.9M | ||
| Q2 24 | $67.4M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
